Financial insights of AMED

MyFinsight

For the quarter ending 2025-06-30.

Income Statement	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Other	-	57,965	58,269*	56,777
Impairment	-	-	12,098*	-
Salaries and benefits	-	131,968	133,514*	134,833
Depreciation and amortization	-	4,447	4,257*	4,774
Miscellaneous, net	4,506	1,508	1,614*	2,522
Cost of service, inclusive of depreciation	-	334,050	370,196*	337,563
Interest income	3,016	2,873	2,659*	2,017
Non-cash compensation	-	6,223	7,197*	6,726
Interest expense	6,415	6,422	7,264*	7,772
Merger-related expenses	-	16,769	23,783*	16,669
Equity in earnings from equity method investments	1,641	1,794	1,158*	1,891
Total operating expenses	-	551,422	609,313*	557,342
Gain on equity method investment	0	48,093	-	-
Revenues	-	594,781	580,037*	587,671
Total other income (expense), net	2,748	47,846	-1,833*	-1,342
Operating income	45,578	43,359	-29,276*	30,329
Income before income taxes	48,326	91,205	-31,109*	28,987
Income tax expense	19,274	29,384	4,359*	12,473
Net income	29,052	61,821	-35,468*	16,514
Net income attributable to noncontrolling interests	968	809	-4,881*	-397
Net income attributable to amedisys, inc	28,084	61,012	-30,587	16,911

Basic EPS	0.85	1.86	-0.935	0.52
Diluted EPS	0.84	1.84	-0.928	0.51
Basic Average Shares	32,849,000	32,793,000	32,703,000	32,745,000
Diluted Average Shares	33,289,000	33,218,000	32,971,000	33,135,000

Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.